Inhibitor Therapeutics INTI
OTC INTI
$0.08 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibitor Therapeutics (INTI) Long-Term Debt Repayments (2009 - 2023)

Updated

Inhibitor Therapeutics (INTI) recorded Long-Term Debt Repayments of $411,000 in FY2023.

Analysis

Inhibitor Therapeutics (INTI) Long-Term Debt Repayments (2009 - 2023) Analysis & Trends

  • The FY2023 figure is the lowest annual Long-Term Debt Repayments since FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Inhibitor Therapeutics 13.90 Mn 6.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 411,000.00
Dec 31, 2014 41,920.00
Dec 31, 2011 457,378.00
Sep 30, 2011 -74,341.00
Jun 30, 2011 -630,486.00
Mar 31, 2011 -48,961.00
Dec 31, 2010 -340,436.00
Jun 30, 2010 -69,509.00
Mar 31, 2010 -71,996.00
Dec 31, 2009 -105,988.00
Sep 30, 2009 76,969.00
Jun 30, 2009 -72,250.00
Mar 31, 2009 -64,109.00
API Access

Inhibitor Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=INTI&period=max&api_key=YOUR_API_KEY